Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-04-02

Clinical Trial Update: Perampanel in Seizure Patients With Primary Glial Brain Tumors [Phase 4]

View source ↗

Summary

Phase 4 study of perampanel for seizures in patients with primary glial brain tumors completed; results were posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Perampanel (perampanel)

Snippet

Sponsor: Duke University | Conditions: Brain Tumor, Primary | Phase 4 | Status: COMPLETED | Results posted: 2018-04-02